Respiratory Medicine and Research

Papers
(The TQCC of Respiratory Medicine and Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Editorial board10
BAP-1 in the diagnosis of malignant pleural mesothelioma9
Different pathways to lung cancer diagnosis in a real-life setting9
French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update9
Epidemiology of interstitial lung diseases in a native Afro-Caribbean population of French West Indies9
An underrecognized phenotype of pulmonary emphysema with marked pulmonary gas exchange but with mild or moderate airway obstruction8
Impact of Remdesivir on long-term outcomes in lung transplant recipients with SARS-CoV-2 infection: a retrospective cohort analysis8
Evaluating the correspondence between the EQ-5D-5L and disease severity and quality of life in adults and adolescents with cystic fibrosis8
Long-term survival comparison between the first and second waves among 265 critical COVID-19 patients admitted to the ICU: A retrospective cohort study8
Sarcoidosis-like disease probably induced by apremilast: A case report7
Impact of pulmonary hypertension on lung cancer management7
Letter to Hitomi Tomohara-Ichishima et al7
Anti-synthetase syndrome: A focus on interstitial lung disease as a diagnostic criteria7
Diaphragm dysfunction evaluated by electroneuromyography in patients with interstitial lung disease (ILD), risks factors and impact on mortality: a retrospective observational study6
Endobronchial valve (EBV) insertion for severe emphysema does not improve skeletal muscle mass or function: A pilot study on 19 patients6
The pandemic effect: The outlook of lung transplantation6
Trends in annual prevalence and incidence of pharmacologically treated idiopathic pulmonary fibrosis in Greece (2019–2023): A nationwide e-prescription study5
Comparative study of the two diagnostic criteria for idiopathic pleuroparenchymal fibroelastosis5
Use of complementary medicines and self-medication practices in cystic fibrosis – MUCAUTOMED study5
Endobronchial ultrasound-guided transbronchial needle injection of cisplatin results in dynamic changes in the tumor immune microenvironment5
Molecular profiling of patients with advanced lung adenocarcinoma diagnosed between 2015 and 2020 in French Polynesia5
Prognostic value of metabolic activity in noncancerous lung areas for stage I lung cancer5
Lung ultrasound and community-acquired pneumonia: from complementary tool to clinical game-changer5
Association of forced oscillation technique measurements with respiratory system compliance and resistance in a 2-compartment physical model5
Pulmonary arterial stiffness as the main correlate of effective arterial elastance in pre- and post-capillary pulmonary hypertension4
Psychiatric disorders and long COVID4
Feasibility of an innovative follow-up method alternating face-to-face consultations and teleconsultations for adult patients with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor 4
Immunoglobulins as a treatment modality for corticosteroid-refractory pemetrexed-induced interstitial lung disease, case report4
18F-FDG uptake by respiratory muscles in acute respiratory insufficiency in a patient with graft versus host disease4
Mid-term pulmonary sequelae after hospitalisation for COVID-19: The French SISCOVID cohort4
Comparison of amikacin lung delivery between AKITA® and eFlow rapid® nebulizers in healthy controls and patients with CF: A randomized cross-over trial3
Pulmonary adverse events of breast silicone implants and silicone injection3
Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with ext3
Organising pneumonia following amivantamab treatment: a case report3
Understanding participation challenges in lung cancer screening program: Findings from the DEP’KP80 trial in France3
Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer3
Pulmonary ultrasound versus chest radiography in the diagnosis of community-acquired pneumonia in adults: an updated systematic review and meta-analysis3
Pulmonary Arterial Hypertension-approved drugs in Pulmonary Hypertension associated with COPD: A systematic literature review3
Exercise testing and counselling within the cystic fibrosis centres in France: A national survey3
Education and implementation of home spirometry in an adolescent cystic fibrosis population3
Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting3
Assessment of the interobserver reliability in discharge decision-making for patients undergoing thoracic surgery based on chest ultrasound compared to chest X-ray findings3
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease3
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients3
Peripheral cellular biomarkers in bronchiectasis3
Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study3
Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa3
Pulmonary arterial hypertension and COVID-19: Piecing the puzzle3
The incidence of pleural infections in Finland2
Diffuse infiltrative lymphocytic syndrome in recently diagnosed HIV patient: a case-report DILS-ILD responsive to steroids2
Radiologist-reported tension features on x-ray are not associated with physiological instability in ED patients with primary spontaneous pneumothorax2
Reply to Gille and collaborators: DM and VC impairment after COVID-12
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization2
Outcomes of cannabis smoking in patients with lung cancer: findings from KBP-CPHG-20202
Update of guidelines for management of Community Acquired pneumonia in adults by the French Infectious Disease Society (SPILF) and the French-Speaking Society of Respiratory Diseases (SPLF)2
Behaviour change interventions for physical activity in adults with chronic obstructive pulmonary disease; A systematic review and meta-analysis2
Sarcoidosis Diagnostic Score (SDS) system: Impact of race, sex, organ involvement and duration of symptoms prior to diagnosis2
Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study2
Real-world management of unresectable stage III non-small-cell lung cancer: Impact of durvalumab consolidation therapy in French clinical practice2
Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?2
Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis2
PDL1-status predicts primary resistance of metastatic, EGFR-mutated non small cell lung cancers to EGFR tyrosine-kinase inhibitors2
Editorial board2
Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors2
Increasing sleep apnoea burden in the elderly in Finland from 1996 to 2018: A national registry study2
Characteristics of lung nodules detected by low-dose CT scan: Results from the French lung cancer screening study DEP KP-802
SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax2
Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting2
Awake prone position in patients with acute hypoxic respiratory failure: A narrative review2
Chalazion and hordeolum associated with Elexacaftor-Tezacaftor-Ivacaftor use in children with cystic fibrosis2
Corrigendum to “Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa” [Respiratory Medicine and Research 86 (2024) 101133]2
Fast pleurodesis combining talc poudrage and indwelling pleural catheter for the management of recurrent malignant pleural effusions2
The impact of deep venous thrombosis on 90 day mortality in chronic obstructive pulmonary disease patients presenting with pulmonary embolism2
Addressing the inequities in interstitial lung disease care outside specialised centres in Australia2
Burden of unexplained dyspnea: a single-center study1
Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis1
A 52-year-old immunocompromised man with an unusual cause of infectious lung cavitary inducing acute respiratory failure1
Does pre-existing respiratory disease affect 3-month outcome following COVID hospitalisation across 4 waves: A prospective cohort analysis1
Does size matter: Diagnostic yield and significance of small intrathoracic lymph nodes sampled on EBUS-TBNA1
Efficacy of bronchial thermoplasty in patients with severe asthma and frequent severe exacerbations: A randomized controlled study✰1
Preoperative DLCO predicts severe early complications after liver transplantation1
Effectiveness of a home-based pulmonary rehabilitation programme in people recovering from a severe and critically COVID-19 infection1
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy1
Drug-induced interstitial lung disease: Indictment for apixaban1
COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study1
Dysbiosis and leaky gut in hyper-inflated COPD patients: Have smoking and exercise training any role?1
Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital1
Increased delays of care during the COVID-19 pandemic: experience of a lung cancer rapid diagnostic center1
Broncho-esophageal fistula: When surgery and endoscopy fail, consider physiological lung exclusion1
Recovery after admission with COVID-19 pneumonia – A follow-up study1
Constraints to the initiation of home non-invasive ventilation and short-term efficacy in different diagnostic groups (as a prelude to an ambulatory shift)1
Severe respiratory syncytial virus infection in older adults – burden, clinical outcomes and implications for care1
Prognostic value of the mini nutritional assessment short-form and SpO₂/FiO₂ ratio at admission for in-hospital mortality in patients with interstitial lung disease1
Home NIV treatment quality in patients with chronic respiratory failure having participated to the French nationwide telemonitoring experimental program (The TELVENT study)1
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version1
Dupilumab-induced rhinitis in severe asthma patients: A case series1
Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Impact of lung hyperinflation on the response to pulmonary hypertension treatment1
Does occupational exposure affect the surgical management of patients with non-small cell lung cancer? A single-center retrospective experience1
Flow-mediated dilation as a marker of endothelial dysfunction in pulmonary diseases: A narrative review1
Disease stage-related survival in idiopathic pulmonary fibrosis patients treated with nintedanib and pirfenidone: An exploratory study1
Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study1
Concomitant ALK translocation and EGFR C797S mutation as resistance mechanisms to osimertinib in an EGFR-mutant NSCLC patient1
Primary spontaneous pneumothorax: French guidelines are ready for launching!1
Anti-mutated citrullinated vimentin antibodies are increased in IPF patients1
Screening for an underlying myeloproliferative neoplasm in patients with chronic thromboembolic pulmonary hypertension1
Real-world outcomes of patients treated with ≥17 cycles of pembrolizumab monotherapy as first-line therapy and for previously treated advanced NSCLC: multicenter observational study in France1
Characteristics, management, and healthcare resources of patients with advanced non–small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national database analysis1
Changes in body weight reflect disease progression in pleuroparenchymal fibroelastosis1
Assessing the effectiveness of inhalation therapy in patients with chronic airway diseases: A new digital measurement1
Response to the comment of Yu Tian et al. on “Increasing sleep apnoea burden in the elderly in Finland from 1996 to 2018: A national registry study”1
Real-world evidence on hospitalization, infection, and vascular outcomes among interstitial lung disease subtypes1
First steps for telemonitoring mechanical cough assistance in people with neuromuscular diseases: The Tele-INEX study1
Bronchiectasis in France: data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC)1
Potential availability of saliva-based reverse transcription-quantitative polymerase chain reaction in extensive screening for asymptomatic individuals as a business continuity strategy during the cor1
The preponderance of genetic variations in paediatric pulmonary hypertension1
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 20221
Awake endoscopic (esophageal) ultrasound using the endobronchial scope (EUS-B) for patients with high risk for sedation1
The intermittent intrapulmonary deflation technique for airway clearance in patients with cystic fibrosis: A randomized trial1
Screening for impaired pulmonary function using peak expiratory flow: Performance of different interpretation strategies1
Real-life evaluation of NIV to CPAP switch in patients with chronic respiratory failure. A case control study1
Long-term effect of tocilizumab on mortality, readmissions, persistent symptoms and lung function in SARS-CoV-2 patients 1 year after hospital discharge: A matched cohort study1
Safety of non-cuffed tunneled central venous catheters in adults with cystic fibrosis1
Cardiac MRI and the “lung phenotype” in pulmonary hypertension: Overlap with group 3 or distinct entity?1
Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study1
Effect of elexacaftor-tezacaftor-ivacaftor on lipid parameters in adults with cystic fibrosis: A single centre preliminary report1
Malignant solitary fibrous tumor of the pleura: A narrative review of clinical characteristics, diagnosis and therapeutic options1
Titanium dental implants-related acute pneumonitis1
Rapid and extensive calcification of pulmonary arteries1
Co-morbid insomnia and obstructive sleep apnea (COMISA) and cardiovascular risk: A scoping review1
Acute hemodynamic response to inhaled treprostinil in pulmonary hypertension associated with interstitial lung disease: a case highlighting unresolved questions1
Classification of systemic lupus erythematosus in patients with interstitial pneumonia with autoimmune features using two different sets of criteria1
Impact of the COVID-19 pandemic on lung cancer diagnosis, treatment, mortality, and survival in Belgium: A population-based study1
Long-acting muscarinic antagonists (LAMA) in asthma: What is the best strategy?1
Operated bronchial carcinoid tumors: impact of lymph node status and histological type on long-term outcomes1
Acute effects of fan therapy on exercise-induced breathlessness in healthy adults and people living with chronic respiratory disease: A systematic review1
Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-191
Temporal evolution of diaphragm thickness and diaphragm excursion among subjects hospitalized with COVID-19: A prospective observational study1
The functional consequences in severe and critical covid-19 survivors – A pilot study1
Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study1
Should segmentectomy indications be extended to NSCLC smaller than 3 cm without lymph node involvement? A retrospective single-center study1
An exposed/unexposed cohort study assessing the effectiveness, the safety and the survival of patients established on home non-invasive ventilation after 80 years old1
Phenotypes and prognosis of systemic sclerosis: A cluster analysis1
Does an interval exercise session compared to a continuous exercise session prevent desaturation induced by exercise in patients with COPD?1
0.10127997398376